Literature DB >> 29652644

Alphaviruses: Serological Evidence of Human Infection in Paraguay (2012-2013).

Fátima Cardozo1, Brenda Konigheim2, Guillermo Albrieu-Llinás2, María Elisa Rivarola2, Javier Aguilar2, Alejandra Rojas1, Agustín Ignacio Quaglia2, Malvina Paez1, Yvalena Guillén1, Adrian Diaz2, María Asunción Vallejos3, Lilian Herebia3, María Lidia Recalde4, Marta Silvia Contigiani2, Laura Mendoza1.   

Abstract

INTRODUCTION: Alphaviruses can produce febrile illness and encephalitis in dead-end hosts such as horses and humans. Within this genus, the Venezuelan Equine Encephalitis virus (VEEV) complex includes pathogenic epizootic subtypes and enzootic subtypes that are not pathogenic in horses (except subtype IE, Mexican strains), although they can cause febrile symptoms in humans. The Rio Negro virus (RNV-VEEV subtype VI) circulates in Argentina, where it was associated with undifferentiated febrile illness. Mayaro (MAYV) and Una (UNAV) viruses belong to a different group, the Semliki Forest virus complex, with confirmed circulation.
OBJECTIVE: The present study aimed to determine RNV, MAYV, and UNAV seroprevalences by plaque reduction neutralization test in 652 samples of Paraguayan individuals mainly from the Central Department, between years 2012 and 2013.
METHODS: Samples with antibodies titer >1:20 against RNV were also tested for Mosso das Pedras-subtype IF, subtype IAB, and Pixuna (PIXV)-subtype IV viruses that belongs to VEEV antigenic complex.
RESULTS: The overall seroprevalence of RNV was 3.83%, and for UNAV it was 0.46%, and no neutralizing antibodies were detected against MAYV in the studied population. Two of the twenty-seven heterotypic samples were positive for PIXV. The 50.1% of neutralizing antibody titers against RNV were high (equal to or greater than 1/640), suggesting recent infections. The effect of age on the prevalence of RNV was negligible.
CONCLUSIONS: These results bring new information about neglected alphaviruses in South America, and these data will serve as the basis for future studies of seroprevalence of other VEEV, and studies to search potential hosts and vectors of these viruses in the region.

Entities:  

Keywords:  Paraguayan human population; Una virus; Venezuelan Equine Encephalitis virus.; alphaviruses; serological evidence

Mesh:

Substances:

Year:  2018        PMID: 29652644     DOI: 10.1089/vbz.2017.2178

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  6 in total

1.  Serologic Evidence of Zoonotic Alphaviruses in Humans from an Indigenous Community in the Peruvian Amazon.

Authors:  Jocelyn G Pérez; Jean-Paul Carrera; Emmanuel Serrano; Yaneth Pittí; Jorge L Maguiña; Gregorio Mentaberre; Andrés G Lescano; Anayansi Valderrama; Pedro Mayor
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

2.  Antibodies for Venezuelan Equine Encephalitis Virus Protect Embryoid Bodies from Chikungunya Virus.

Authors:  Emily M Schultz; TyAnthony J Jones; Kelli L Barr
Journal:  Viruses       Date:  2020-02-27       Impact factor: 5.048

Review 3.  Epidemic Alphaviruses: Ecology, Emergence and Outbreaks.

Authors:  Sasha R Azar; Rafael K Campos; Nicholas A Bergren; Vidyleison N Camargos; Shannan L Rossi
Journal:  Microorganisms       Date:  2020-08-01

4.  An Environmental Niche Model to Estimate the Potential Presence of Venezuelan Equine Encephalitis Virus in Costa Rica.

Authors:  Bernal León; Carlos Jiménez-Sánchez; Mónica Retamosa-Izaguirre
Journal:  Int J Environ Res Public Health       Date:  2020-12-30       Impact factor: 3.390

5.  Alphavirus Identification in Neotropical Bats.

Authors:  Lucía Moreira Marrero; Germán Botto Nuñez; Sandra Frabasile; Adriana Delfraro
Journal:  Viruses       Date:  2022-01-28       Impact factor: 5.048

6.  Endemic and Epidemic Human Alphavirus Infections in Eastern Panama: An Analysis of Population-Based Cross-Sectional Surveys.

Authors:  Jean-Paul Carrera; Zulma M Cucunubá; Karen Neira; Ben Lambert; Yaneth Pittí; Jesus Liscano; Jorge L Garzón; Davis Beltran; Luisa Collado-Mariscal; Lisseth Saenz; Néstor Sosa; Luis D Rodriguez-Guzman; Publio González; Andrés G Lescano; Reneé Pereyra-Elías; Anayansi Valderrama; Scott C Weaver; Amy Y Vittor; Blas Armién; Juan-Miguel Pascale; Christl A Donnelly
Journal:  Am J Trop Med Hyg       Date:  2020-10-22       Impact factor: 3.707

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.